GSK Blasts Teva's Use Of Pom Ruling To Nix False-Ad Suit
GlaxoSmithKline LLC criticized Teva Pharmaceuticals USA Inc.'s request for reconsideration of a Pennsylvania federal judge's refusal to dismiss GSK's suit, which accuses Teva of falsely advertising a generic antidepressant as equivalent...To view the full article, register now.
Already a subscriber? Click here to view full article